These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6630364)

  • 21. Assessment of laboratory quality in urine drug testing. A proficiency testing pilot study.
    Davis KH; Hawks RL; Blanke RV
    JAMA; 1988 Sep 23-30; 260(12):1749-54. PubMed ID: 3411757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Confirmed identification of biotransformed drugs of abuse in urine.
    Baden MM; Valanju NN; Verma SK; Valanju SN
    Am J Clin Pathol; 1972 Jan; 57(1):43-51. PubMed ID: 5008893
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept.
    Wissenbach DK; Meyer MR; Remane D; Philipp AA; Weber AA; Maurer HH
    Anal Bioanal Chem; 2011 Jul; 400(10):3481-9. PubMed ID: 21533799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine identification of drugs of abuse in human urine. 3. Differential elution of the XAD-2 resin.
    Bastos ML; Jukofsky D; Mulé SJ
    J Chromatogr; 1973 Jun; 81(1):93-8. PubMed ID: 4725419
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug population in one thousand geographically distributed urine specimens.
    Jones DW; Adams D; Martel PA; Rousseau RJ
    J Anal Toxicol; 1985; 9(3):125-30. PubMed ID: 4010236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of drugs of abuse by high-performance thin-layer chromatography.
    Gübitz G; Wintersteiger R
    J Anal Toxicol; 1980; 4(3):141-4. PubMed ID: 7421148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of thin-layer chromatography and of other methods for the detection of drug abuse.
    Davidow B; Fastlich E
    Prog Clin Pathol; 1973; 5():85-98. PubMed ID: 4782458
    [No Abstract]   [Full Text] [Related]  

  • 28. A review of laboratory methods for the analysis of opiates and diluents in illicit drug traffic.
    Navaratnam V; Fei HK
    Bull Narc; 1984; 36(1):15-23. PubMed ID: 6564899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs of abuse screening in the West Midlands: a 6 year retrospective survey of results.
    George S; Braithwaite RA
    Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():473-8. PubMed ID: 7832574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of six methods for the detection of drugs of abuse in urine.
    Simpson D; Jarvie DR; Heyworth R
    Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():172-81. PubMed ID: 2729861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the ion-trap mass spectrometer for routine qualitative and quantitative analysis of drugs of abuse extracted from urine.
    Vorce SP; Sklerov JH; Kalasinsky KS
    J Anal Toxicol; 2000 Oct; 24(7):595-601. PubMed ID: 11043665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for drugs of abuse in urine samples from a drug addiction center.
    Peat MA
    Clin Toxicol; 1976; 9(2):203-19. PubMed ID: 939075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated online solid phase extraction ultra high performance liquid chromatography method coupled with tandem mass spectrometry for determination of forty-two therapeutic drugs and drugs of abuse in human urine.
    Chiuminatto U; Gosetti F; Dossetto P; Mazzucco E; Zampieri D; Robotti E; Gennaro MC; Marengo E
    Anal Chem; 2010 Jul; 82(13):5636-45. PubMed ID: 20533830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine testing in the detection of drugs of abuse.
    Schwartz RH
    Arch Intern Med; 1988 Nov; 148(11):2407-12. PubMed ID: 3056313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug screening: evaluation of the Toxi-Lab TLC system.
    Jarvie DR; Simpson D
    Ann Clin Biochem; 1986 Jan; 23 ( Pt 1)():76-84. PubMed ID: 3767255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: an external quality assessment scheme using clinically realistic urine samples. Steering Committee for the United Kingdom National External Quality Assessment Scheme for Drugs of Abuse in Urine.
    Wilson JF; Smith BL
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():592-600. PubMed ID: 10505208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scientific issues in drug testing. Council on Scientific Affairs.
    JAMA; 1987 Jun; 257(22):3110-4. PubMed ID: 3586230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of drugs of abuse found in testing of illicit drug seizures and urinalysis of selected population in Hong Kong.
    Cheng WC; Dao KL
    Forensic Sci Int; 2019 Jun; 299():6-16. PubMed ID: 30954006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug testing in the military--technical and legal problems.
    Irving J
    Clin Chem; 1988 Mar; 34(3):637-40. PubMed ID: 3349623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.